July 31, 2013
Kazuhiro Hashimoto, Chair of Investigative Committee, Gives Briefing in Tokyo Blood pressure data had been “manipulated” in the JIKEI Heart Study on Novartis Pharma’s top-selling antihypertensive Diovan (valsartan), the university that led the trial concluded in an interim report on...read more